Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRT (Contrast agents MRT).php on line 2
MRT (Contrast agents MRT)
LE WE PMID CA
MRT (Contrast agents MRT)6562MRT (Kontrastmittel MRT)

Atherosclerosis (BASKET)

Imaging (Molecular)

Liver (MRT)

MRT (Contrast agents MRT)

MRT (Instrumentation)

Nanomedicine

Reporter protein

1991  
1
Advances in contrast-enhanced MR imaging. Gastrointestinal contrast agents.
[1898795] AJR Am J Roentgenol 156(2): 252-4 (1991)
1991  
2
Advances in contrast-enhanced MR imaging. Nonneurologic applications.
[1898794] AJR Am J Roentgenol 156(2): 245-52 (1991)
1991  
3
Advances in contrast-enhanced MR imaging. Neurologic applications.
[1898793] AJR Am J Roentgenol 156(2): 239-45 (1991)
1991  
4
Advances in contrast-enhanced MR imaging. Principles.
[1898792] AJR Am J Roentgenol 156(2): 236-9 (1991)
2009  
5
Role of chelates in magnetic resonance imaging studies.
[19841554] J Cancer Res Ther 5(3): 148-53 (2009)
2006  
6
Contrast agents used in MR imaging of the liver.
[16538580] Diagn Interv Radiol 12(1): 22-30 (2006)
2009  
7
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
[18843256] Kidney Int 75(5): 465-74 (2009)
2010  
8
Development of responsive lanthanide-based magnetic resonance imaging and luminescent probes for biological applications.
[20930392] Chem Pharm Bull (Tokyo) 58(10): 1283-94 (2010)
2008  
9
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.
[18324368] Basic Res Cardiol 103(2): 122-30 (2008)
2008  
10
2009  
11
2009  
12
Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.
[19938038] J Magn Reson Imaging 30(6): 1259-67 (2009)
2010  
13
Molecular MR imaging of cancer gene therapy: ferritin transgene reporter takes the stage.
[20585193] Magn Reson Med Sci 9(2): 37-47 (2010)
2010  
14
An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
[19883911] Atherosclerosis 209(1): 18-27 (2010)
2010  
15
Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.
[21611034] Biomed Imaging Interv J 6(2): e12 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRT (Contrast agents MRT).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRT (Contrast agents MRT).php on line 92